The ClearSEEK™ PIK3CA Panel enables tumor profiling studies of breast cancer specimens. It detects 20 clinically relevant variants from PIK3CA. Identifies variants at as low as 1% variant allele frequency. Uses as little as 10 ng of DNA. Takes 1 hour of hands-on time and 8 hours of total time.